Search - tctmd.com

Displaying 761 - 780 of 4220

Sort: Relevancy | Date

News Daily News

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Michael O'Riordan

July 12, 2023

News Daily News

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

Todd Neale

July 10, 2023

News Daily News

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

Caitlin E. Cox

July 06, 2023

Podcast TCTMD Talking Points

The COMPLETE Trial

July 05, 2023

News Daily News

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Todd Neale

July 03, 2023

News Daily News

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Caitlin E. Cox

June 30, 2023

News Conference News ADA 2023

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Shelley Wood

June 29, 2023

News Conference News ADA 2023

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

L.A. McKeown

June 28, 2023

News Conference News ADA 2023

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Michael O'Riordan

June 28, 2023

News Daily News

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

Michael O'Riordan

June 23, 2023

News Daily News

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Shelley Wood

June 22, 2023

News Daily News

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Michael O'Riordan

June 22, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

News Daily News

FDA Approves Colchicine for Decreasing CV Events

Caitlin E. Cox

June 20, 2023

News Daily News

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Michael O'Riordan

June 19, 2023

News Daily News

Randomized Trial Supports Using Hearts Donated After Circulatory Death

Caitlin E. Cox

June 19, 2023

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News TVT 2023

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

Shelley Wood

June 14, 2023

Podcast TCTMD Talking Points

The EDIT-CMD Trial

June 14, 2023

Advertisement

EMA Investigating Suicidal Thinking With GLP-1 Drugs for Weight Loss

Frail Patients Also Benefit From Intensive BP Lowering: SPRINT Analysis

Keto Diet for Heart Failure? What Clinicians, Patients Need to Know

The COMPLETE Trial

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Over Decades, Women Still Missing in NIH-Funded Trials for CVD

Oral, Daily Semaglutide Cuts Pounds in Nondiabetic Patients: OASIS 1

Dramatic Weight Loss, Cardiometabolic Improvement With Retatrutide

Big Reductions in ASCVD Events With Bempedoic Acid in Primary Prevention

Global Numbers Paint Grim Picture of GDMT Uptake, Costs, and HF Outcomes

PA Catheters in Cardiogenic Shock: Patchy Usage, Potential Gains

Aspirin Use Ups Risk of Anemia in Elderly Patients: ASPREE

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

FDA Approves Colchicine for Decreasing CV Events

US Athlete’s Death Highlights Risk of Hypertensive Disorders of Pregnancy

Randomized Trial Supports Using Hearts Donated After Circulatory Death

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Five-Year Follow-up Reassures on Severe Patient-Prosthesis Mismatch in TAVI

The EDIT-CMD Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content